Metsera’s long-acting GLP-1 shows promise, Trump’s Greenland feud threatens Novo, Lilly and Novo seek to restrict GLP-1 compounding, and more.
The Gut Punch Weekly #2
Metsera’s long-acting GLP-1 shows promise, Trump’s Greenland feud threatens Novo, Lilly and Novo seek to restrict GLP-1 compounding, and more.